◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DCTH

Delcath Systems Inc (DCTH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-30

Delcath Systems Inc (DCTH) operates in the MEDICAL DEVICES industry and is headquartered in Queensbury, United States with about 156 employees. Its market capitalization is roughly $500 million. In the fiscal year ended 2025-12-31, DCTH reported $85M in revenue and $3M in net income.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Interactive charts & full statements → Open the DCTH valuation workbench →

DCTH Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$95M	$85M	$37M	$2M	$3M	$4M	$2M	$2M	$3M	$3M	$2M	$2M	$1M	$1M	$0M	—	—	—	—	—	—
Gross Profit	$83M	$73M	$31M	$1M	$2M	$3M	$1M	$1M	$2M	$2M	$1M	$1M	$1M	$0M	$0M	—	—	—	—	—	—
Gross Margin %	87.1%	86.2%	83.4%	69.2%	74.8%	81.1%	61.1%	54.5%	70.4%	74.2%	72.4%	73.6%	72.8%	41.3%	88.7%	—	—	—	—	—	—
Operating Income (EBIT)	($2M)	$1M	($12M)	($38M)	($34M)	($25M)	($21M)	($20M)	($27M)	($18M)	($16M)	($15M)	($19M)	($33M)	($54M)	($46M)	($31M)	($14M)	($8M)	($7M)	($12M)
Operating Margin %	-1.9%	0.8%	-33.4%	-1849.0%	-1245.0%	-690.0%	-1294.2%	-1260.0%	-794.6%	-669.1%	-825.3%	-870.6%	-1805.8%	-4179.6%	-15569.6%	—	—	—	—	—	—
Net Income	$1M	$3M	($26M)	($48M)	($37M)	($26M)	($24M)	($9M)	($19M)	($45M)	($18M)	($15M)	($17M)	($30M)	($52M)	($31M)	($47M)	($22M)	($7M)	($4M)	($11M)
Net Margin %	0.6%	3.2%	-70.9%	-2308.9%	-1342.7%	-721.5%	-1467.6%	-562.0%	-564.2%	-1661.8%	-902.2%	-841.7%	-1625.9%	-3838.5%	-14990.8%	—	—	—	—	—	—
EBITDA	$2M	$4M	($26M)	($46M)	($34M)	($24M)	($24M)	($4M)	($11M)	($23M)	($16M)	($14M)	($16M)	($29M)	($53M)	($30M)	($46M)	($22M)	($7M)	($4M)	($11M)
Earnings Per Share (EPS)	$0.01	$0.07	$-0.93	$-2.94	$-4.12	$-3.59	$-8.34	$-342.82	$-503,853.21	$-2,255,850,000.00	$-781,347.83	—	—	—	—	—	$-97,460.64	—	—	—	—
Shares Outstanding (M)	40M	40M	29M	16M	9M	7M	3M	0M	0M	0M	0M	0M	0M	0M	0M	0M	0M	0M	0M	0M	0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DCTH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$29M	$25M	$21M	$21M	$24M	$20M	$15M	$11M
Gross Profit	$26M	$21M	$18M	$18M	$21M	$17M	$13M	$10M
Gross Margin %	89.8%	85.0%	85.5%	87.2%	86.3%	85.6%	85.9%	85.4%
Operating Income (EBIT)	$2M	($2M)	($2M)	$0M	$3M	$1M	$3M	($1M)
Operating Margin %	8.2%	-6.6%	-10.5%	-1.9%	10.7%	3.2%	20.1%	-11.2%
Net Income	$3M	($1M)	($2M)	$1M	$3M	$1M	($3M)	$2M
Net Margin %	9.2%	-4.3%	-9.2%	4.0%	11.2%	5.4%	-22.5%	16.6%
EBITDA	$3M	($1M)	($1M)	$0M	$3M	$1M	$10M	$2M
Earnings Per Share (EPS)	$0.07	$-0.03	$-0.05	$0.02	$0.07	$0.03	$-0.12	$0.06
Shares Outstanding (M)	40M	36M	40M	40M	40M	40M	28M	32M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DCTH Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$20M	$23M	($19M)	($31M)	($25M)	($23M)	($23M)	($24M)	($15M)	($15M)	($14M)	($16M)	($16M)	($34M)	($50M)	($37M)	($24M)	($10M)	($7M)	($6M)	($9M)
Capital Expenditures (CapEx)	$2M	$2M	$1M	$0M	$0M	$0M	$1M	$0M	$0M	$1M	$0M	$0M	$0M	$0M	$2M	$3M	$2M	$1M	$0M	$0M	$5M
Free Cash Flow (FCF)	$18M	$21M	($19M)	($31M)	($25M)	($23M)	($24M)	($24M)	($15M)	($16M)	($14M)	($17M)	($16M)	($34M)	($52M)	($40M)	($26M)	($11M)	($7M)	($6M)	($15M)
FCF Margin %	18.4%	24.6%	-51.7%	-1516.2%	-925.3%	-639.9%	-1436.8%	-1500.8%	-434.6%	-586.4%	-726.5%	-949.6%	-1458.9%	-4334.7%	-15065.3%	—	—	—	—	—	—
Dividends Paid	—	—	—	$52M	—	—	$0M	—	—	$1M	—	—	—	—	—	—	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DCTH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$6M	$1M	$8M	$5M	$7M	$2M	($1M)	($4M)
Capital Expenditures (CapEx)	$1M	$1M	$1M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	$5M	$0M	$8M	$4M	$7M	$2M	($1M)	($4M)
FCF Margin %	17.9%	1.1%	37.1%	21.0%	28.5%	10.4%	-8.2%	-34.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DCTH Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$137M	$124M	$77M	$39M	$18M	$33M	$35M	$14M	$7M	$9M	$35M	$16M	$24M	$37M	$30M	$35M	$51M	$37M	$11M	$18M	$9M
Cash & Cash Equivalents	$48M	$43M	$32M	$13M	$8M	$23M	$29M	$10M	$3M	$4M	$4M	$13M	$20M	$31M	$24M	$26M	$46M	$35M	$11M	$8M	$6M
Total Liabilities	$16M	$12M	$8M	$23M	$24M	$21M	$13M	$21M	$22M	$8M	$37M	$7M	$6M	$7M	$10M	$9M	$21M	$13M	$1M	$2M	$1M
Total Debt (Short + Long-Term)	$0M	$0M	$0M	$10M	$16M	$16M	$2M	$3M	$2M	$13M	$13M	$0M	$0M	$4M	$5M	$5M	$297M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$121M	$111M	$69M	$16M	($6M)	$12M	$22M	($6M)	($15M)	$1M	($1M)	$9M	$18M	$30M	$20M	$26M	$29M	$24M	$10M	$16M	$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DCTH viewer.

Other Companies in MEDICAL DEVICES

TCMD · Tactile Systems Technology Inc — $561 million
AVR · Anteris Technologies Global Corp. Common Stock — $545 million
SGHT · Sight Sciences Inc — $513 million
SENS · Senseonics Holdings, Inc. Common Stock — $503 million
CERS · Cerus Corporation — $472 million
SSII · SS Innovations International Inc. Common Stock — $467 million
BWAY · Brainsway Ltd — $449 million
NPCE · Neuropace Inc — $422 million

← DCSH All “D” companies DCW →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.